HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

NCT00980239 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Advanced Cancer

Interventions

DRUG: Irinotecan
DRUG: Bevacizumab
DRUG: Oxaliplatin
DRUG: Cetuximab

Sponsor

M.D. Anderson Cancer Center